CVA Family Office’s Nomura Holdings NMR Stock Holding History

CVA Family Office’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Hold	135	–	–	﹤0.01%	1618
2026 Q1	$1.06K	Buy	+135	New	+$1.16K	﹤0.01%	1640

Other funds holding NMR

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CVA Family Office's NMR Position: Q2 2026 in Review

CVA Family Office held its Nomura Holdings (NMR) position steady in Q2 2026 at 135 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

CVA Family Office first reported a position in NMR in Q1 2026 and has held it in 2 quarters since. 300 funds tracked by Wall St. Rank hold NMR as of Q2 2026.

CVA Family Office held 135 shares of Nomura Holdings worth $1.19K as of Q2 2026.
CVA Family Office left its Nomura Holdings share count unchanged in Q2 2026.
Nomura Holdings made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1618 holding.
CVA Family Office first reported a position in Nomura Holdings in Q1 2026 and has held it in 2 quarters since.
300 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.